Recent Articles By The Author
I continue to believe that smaller cities will be huge winners in coming years as technology enables virtual work forces.
The euphoria in biotech stocks Monday was a nice change of pace. It also brought to the forefront some lessons about M&A in this industry.
Chatham Lodging Trust, Summit Materials and Vistra Corp. all have seen their CEOs add to their holdings in these companies.
BioXcel Therapeutics and Avadel Pharmaceuticals are new additions to my personal portfolio based on their promising drug prospects.
Use long-dated calls to take some of risk out of this inherently high-beta space.
This covered call strategy is an effective way to navigate an overbought market.
A handful of deals have been announced this week alone and they give rise to expectations of more acquisitions to come.
There are and will continue to be winners and losers as the outmigration from big cities isn't likely to abate anytime soon.
As the impact of Covid-19 wanes battered sectors such as hospitality should start to revive, which makes Chatham Lodging Trust an attractive prospect.